Compare COEP & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COEP | SAMG |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | United States |
| Employees | 6 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.2M | 91.5M |
| IPO Year | N/A | 2012 |
| Metric | COEP | SAMG |
|---|---|---|
| Price | $16.40 | $11.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.3K | 31.4K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 6.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $91,358,000.00 |
| Revenue This Year | N/A | $8.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $370.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $11.03 |
| 52 Week High | $21.41 | $16.97 |
| Indicator | COEP | SAMG |
|---|---|---|
| Relative Strength Index (RSI) | 72.18 | 31.77 |
| Support Level | $13.77 | $11.05 |
| Resistance Level | $19.19 | $13.86 |
| Average True Range (ATR) | 1.15 | 0.36 |
| MACD | 0.47 | -0.02 |
| Stochastic Oscillator | 87.62 | 13.76 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.